Ads
related to: pyruvate kinase- Website For Patients
Visit this website if you are
a patient seeking information.
- Trials and Results
Learn about the first phase
3 pivotal trial program.
- Safety Data
Learn about the this pk deficiency
treatment's safety profile.
- Mechanism of Action
See how this pk deficiency
treatment works in your body.
- Website For Patients
Search results
Results From The WOW.Com Content Network
Pyruvate kinase is the enzyme involved in the last step of glycolysis.It catalyzes the transfer of a phosphate group from phosphoenolpyruvate (PEP) to adenosine diphosphate (ADP), yielding one molecule of pyruvate and one molecule of ATP. [1]
Pyruvate kinase deficiency is an inherited metabolic disorder of the enzyme pyruvate kinase which affects the survival of red blood cells. [ 4 ] [ 5 ] Both autosomal dominant and recessive inheritance have been observed with the disorder; classically, and more commonly, the inheritance is autosomal recessive .
Pyruvate kinase PKLR is an enzyme that in humans is encoded by the PKLR gene. [5] [6] The protein encoded by this gene is a pyruvate kinase that catalyzes the production of pyruvate and ATP from phosphoenolpyruvate. Defects in this enzyme, due to gene mutations or genetic variations, are the common cause of chronic hereditary nonspherocytic ...
Pyruvate kinase isozymes M1/M2 (PKM1/M2), also known as pyruvate kinase muscle isozyme (PKM), pyruvate kinase type K, cytosolic thyroid hormone-binding protein (CTHBP), thyroid hormone-binding protein 1 (THBP1), or opa-interacting protein 3 (OIP3), is an enzyme that in humans is encoded by the PKM2 gene.
Tumor M2-PK is a synonym for the dimeric form of the pyruvate kinase isoenzyme type M2 (), a key enzyme within tumor metabolism.Tumor M2-PK can be elevated in many tumor types, rather than being an organ-specific tumor marker such as PSA.
The FDA approved mitapivat based on evidence from two clinical trials of 107 participants with pyruvate kinase deficiency. [3] Trial 1 (NCT03548220) of 80 adults with pyruvate kinase deficiency who did not receive regular blood transfusions and trial 2 (NCT03559699) of 27 adults with pyruvate kinase deficiency who received regular blood transfusions. [3]
Ad
related to: pyruvate kinase